248 | Chapter 11 departments. Their emergence is strategic, given that creating a decision aid is a timeconsuming and complex task due to its multidisciplinary nature. Additionally, there are associated costs, such as web hosting, creating videos and animations, and ensuring regular maintenance and updates. Quality assurance for PDAs is maintained through adherence to the International Patient Decision Aid Standards (IPDAS) criteria22. These guidelines ensure that PDAs are evidence-based, accurate, and unbiased, promoting clarity and consistency while helping patients make well-informed decisions. We’ve developed a PDA for patients with early-stage oropharyngeal squamous cell carcinoma (OPSCC), providing them with valuable guidance in navigating treatment decisions between radiation therapy and transoral (robotic) surgery (Chapter 6). Despite incorporating numerous images and explanatory videos, challenges remain for those without computer access or literacy skills, highlighting the need for more inclusive tools that can accommodate diverse patient needs. The impact of the PDA for advanced laryngeal cancer showed that knowledge increased significantly, as that the level of DC. Despite promising outcomes, integrating PDAs into routine clinical practice poses challenges, necessitating concerted efforts to address logistical barriers, healthcare provider attitudes, and institutional policies. Ultimately, fostering a culture that prioritizes patient involvement in decision-making is essential to ensure that PDAs fulfill their potential in supporting informed decision-making and enhancing patient outcomes. Potential solutions include assigning specific individuals to oversee the process, discussing PDAs during multidisciplinary team meetings, and incorporating them into patient portals or environments. Recognizing that tasks requiring time and effort can easily be overlooked or deprioritized, it’s crucial to make the implementation as straightforward as possible.
RkJQdWJsaXNoZXIy MTk4NDMw